CA2049986A1 - Antigenes de ricketties a des fins de vaccination et de diagnostique - Google Patents

Antigenes de ricketties a des fins de vaccination et de diagnostique

Info

Publication number: CA2049986A1
Authority: CA; Canada
Prior art keywords: serine; glutamine; amino acid; glycine; antigenic peptide
Prior art date: 1989-04-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002049986A

Other languages

English (en)

Inventor

Travis C. Mcguire

Guy H. Palmer

Anthony F. Barbet

William C. Davis

David R. Allred

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Washington State University Research Foundation

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-04-06

Filing date

1990-03-30

Publication date

1990-10-07

1990-03-30 Application filed by Individual filed Critical Individual

1990-10-07 Publication of CA2049986A1 publication Critical patent/CA2049986A1/fr

Status Abandoned legal-status Critical Current

Links

239000000427 antigen Substances 0.000 title claims abstract description 81
108091007433 antigens Proteins 0.000 title claims abstract description 81
102000036639 antigens Human genes 0.000 title claims abstract description 81
241000606651 Rickettsiales Species 0.000 title claims abstract description 48
238000003745 diagnosis Methods 0.000 title description 5
238000002255 vaccination Methods 0.000 title description 3
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 173
230000000890 antigenic effect Effects 0.000 claims abstract description 124
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 65
229920001184 polypeptide Polymers 0.000 claims abstract description 55
241000606665 Anaplasma marginale Species 0.000 claims abstract description 47
238000000034 method Methods 0.000 claims abstract description 40
230000001939 inductive effect Effects 0.000 claims abstract description 21
230000028993 immune response Effects 0.000 claims abstract description 20
108010052285 Membrane Proteins Proteins 0.000 claims abstract description 19
238000002405 diagnostic procedure Methods 0.000 claims abstract description 12
241000282849 Ruminantia Species 0.000 claims abstract description 4
238000010353 genetic engineering Methods 0.000 claims abstract description 3
102400000368 Surface protein Human genes 0.000 claims abstract 4
150000001413 amino acids Chemical group 0.000 claims description 212
108090000623 proteins and genes Proteins 0.000 claims description 164
102000004169 proteins and genes Human genes 0.000 claims description 117
241000606646 Anaplasma Species 0.000 claims description 88
108020004414 DNA Proteins 0.000 claims description 82
208000015181 infectious disease Diseases 0.000 claims description 53
230000014509 gene expression Effects 0.000 claims description 40
150000007523 nucleic acids Chemical class 0.000 claims description 35
230000002163 immunogen Effects 0.000 claims description 34
108020004707 nucleic acids Proteins 0.000 claims description 33
102000039446 nucleic acids Human genes 0.000 claims description 33
229960005486 vaccine Drugs 0.000 claims description 30
244000045947 parasite Species 0.000 claims description 27
239000012634 fragment Substances 0.000 claims description 26
241001465754 Metazoa Species 0.000 claims description 25
238000012360 testing method Methods 0.000 claims description 11
230000001681 protective effect Effects 0.000 claims description 10
230000015572 biosynthetic process Effects 0.000 claims description 9
238000004519 manufacturing process Methods 0.000 claims description 9
210000002966 serum Anatomy 0.000 claims description 9
238000003786 synthesis reaction Methods 0.000 claims description 9
239000004471 Glycine Substances 0.000 claims description 8
108091028043 Nucleic acid sequence Proteins 0.000 claims description 8
230000004224 protection Effects 0.000 claims description 8
241000606701 Rickettsia Species 0.000 claims description 7
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
108020004511 Recombinant DNA Proteins 0.000 claims description 4
238000001502 gel electrophoresis Methods 0.000 claims description 4
241000894007 species Species 0.000 claims description 4
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
108020004711 Nucleic Acid Probes Proteins 0.000 claims description 2
239000002853 nucleic acid probe Substances 0.000 claims description 2
LCDIBPKMVCTKGZ-PREAGGAWSA-N 2-aminoacetic acid (2S)-2,5-diamino-5-oxopentanoic acid Chemical compound N[C@@H](CCC(N)=O)C(=O)O.N[C@@H](CCC(N)=O)C(=O)O.N[C@@H](CCC(N)=O)C(=O)O.NCC(=O)O.NCC(=O)O LCDIBPKMVCTKGZ-PREAGGAWSA-N 0.000 claims 15
LLCMWYISNWKLLC-YMFPBBHPSA-N 2-aminoacetic acid (2S)-2-amino-3-hydroxypropanoic acid (2S)-2-amino-3-methylbutanoic acid (2S)-2-aminopentanedioic acid (2S)-2,5-diamino-5-oxopentanoic acid Chemical compound N[C@@H](CO)C(=O)O.N[C@@H](CCC(N)=O)C(=O)O.N[C@@H](CO)C(=O)O.N[C@@H](CO)C(=O)O.N[C@@H](C(C)C)C(=O)O.N[C@@H](CO)C(=O)O.N[C@@H](CO)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](CCC(N)=O)C(=O)O.N[C@@H](CCC(N)=O)C(=O)O.N[C@@H](CCC(N)=O)C(=O)O.NCC(=O)O LLCMWYISNWKLLC-YMFPBBHPSA-N 0.000 claims 15
102000053602 DNA Human genes 0.000 claims 3
238000010647 peptide synthesis reaction Methods 0.000 claims 3
241000124008 Mammalia Species 0.000 claims 2
OXYWQCYQVVUQTM-ZRIQBPNSSA-N 2-aminoacetic acid (2S)-2,5-diamino-5-oxopentanoic acid Chemical compound N[C@@H](CCC(N)=O)C(=O)O.N[C@@H](CCC(N)=O)C(=O)O.N[C@@H](CCC(N)=O)C(=O)O.NCC(=O)O OXYWQCYQVVUQTM-ZRIQBPNSSA-N 0.000 claims 1
230000037230 mobility Effects 0.000 abstract description 16
102000018697 Membrane Proteins Human genes 0.000 abstract description 15
208000006730 anaplasmosis Diseases 0.000 abstract description 11
238000004587 chromatography analysis Methods 0.000 abstract description 9
239000011159 matrix material Substances 0.000 abstract description 8
238000011282 treatment Methods 0.000 abstract description 5
239000003599 detergent Substances 0.000 abstract description 4
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
235000018102 proteins Nutrition 0.000 description 114
210000004027 cell Anatomy 0.000 description 62
239000013612 plasmid Substances 0.000 description 55
241000588724 Escherichia coli Species 0.000 description 30
241000283690 Bos taurus Species 0.000 description 28
210000003743 erythrocyte Anatomy 0.000 description 28
210000004408 hybridoma Anatomy 0.000 description 28
241000283973 Oryctolagus cuniculus Species 0.000 description 23
235000001014 amino acid Nutrition 0.000 description 23
229940024606 amino acid Drugs 0.000 description 23
238000003556 assay Methods 0.000 description 20
239000000499 gel Substances 0.000 description 20
241000894006 Bacteria Species 0.000 description 16
241000699670 Mus sp. Species 0.000 description 15
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 15
210000004369 blood Anatomy 0.000 description 15
239000008280 blood Substances 0.000 description 15
244000309466 calf Species 0.000 description 15
108700028369 Alleles Proteins 0.000 description 14
239000002253 acid Substances 0.000 description 14
238000001114 immunoprecipitation Methods 0.000 description 13
238000006386 neutralization reaction Methods 0.000 description 13
102000004190 Enzymes Human genes 0.000 description 12
108090000790 Enzymes Proteins 0.000 description 12
230000027455 binding Effects 0.000 description 12
229940088598 enzyme Drugs 0.000 description 12
206010035226 Plasma cell myeloma Diseases 0.000 description 11
238000006243 chemical reaction Methods 0.000 description 11
201000000050 myeloid neoplasm Diseases 0.000 description 11
239000006228 supernatant Substances 0.000 description 11
239000002671 adjuvant Substances 0.000 description 10
238000004458 analytical method Methods 0.000 description 10
239000000203 mixture Substances 0.000 description 10
230000036961 partial effect Effects 0.000 description 10
239000000047 product Substances 0.000 description 10
239000000523 sample Substances 0.000 description 10
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 9
108010038807 Oligopeptides Proteins 0.000 description 9
102000015636 Oligopeptides Human genes 0.000 description 9
108020004705 Codon Proteins 0.000 description 8
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
208000030852 Parasitic disease Diseases 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
238000010367 cloning Methods 0.000 description 8
238000003119 immunoblot Methods 0.000 description 8
229930182817 methionine Natural products 0.000 description 8
229920002401 polyacrylamide Polymers 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
208000009182 Parasitemia Diseases 0.000 description 7
238000002105 Southern blotting Methods 0.000 description 7
238000010586 diagram Methods 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
230000003053 immunization Effects 0.000 description 7
108091008146 restriction endonucleases Proteins 0.000 description 7
XKZCXMNMUMGDJG-AWEZNQCLSA-N (2s)-3-[(6-acetylnaphthalen-2-yl)amino]-2-aminopropanoic acid Chemical compound C1=C(NC[C@H](N)C(O)=O)C=CC2=CC(C(=O)C)=CC=C21 XKZCXMNMUMGDJG-AWEZNQCLSA-N 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
239000000020 Nitrocellulose Substances 0.000 description 6
239000007983 Tris buffer Substances 0.000 description 6
230000001154 acute effect Effects 0.000 description 6
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
238000002649 immunization Methods 0.000 description 6
238000012986 modification Methods 0.000 description 6
230000004048 modification Effects 0.000 description 6
230000003472 neutralizing effect Effects 0.000 description 6
229920001220 nitrocellulos Polymers 0.000 description 6
239000008188 pellet Substances 0.000 description 6
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
239000013598 vector Substances 0.000 description 6
108091003079 Bovine Serum Albumin Proteins 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
108700026244 Open Reading Frames Proteins 0.000 description 5
229920002684 Sepharose Polymers 0.000 description 5
238000013459 approach Methods 0.000 description 5
239000000872 buffer Substances 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
230000029087 digestion Effects 0.000 description 5
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
230000006870 function Effects 0.000 description 5
239000012133 immunoprecipitate Substances 0.000 description 5
230000001976 improved effect Effects 0.000 description 5
238000002347 injection Methods 0.000 description 5
239000007924 injection Substances 0.000 description 5
239000002953 phosphate buffered saline Substances 0.000 description 5
102000054765 polymorphisms of proteins Human genes 0.000 description 5
238000003127 radioimmunoassay Methods 0.000 description 5
238000012216 screening Methods 0.000 description 5
238000006467 substitution reaction Methods 0.000 description 5
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 5
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 4
210000001744 T-lymphocyte Anatomy 0.000 description 4
241000700605 Viruses Species 0.000 description 4
229960000723 ampicillin Drugs 0.000 description 4
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
210000003567 ascitic fluid Anatomy 0.000 description 4
239000004202 carbamide Substances 0.000 description 4
210000000349 chromosome Anatomy 0.000 description 4
238000001514 detection method Methods 0.000 description 4
239000003085 diluting agent Substances 0.000 description 4
239000000284 extract Substances 0.000 description 4
230000004927 fusion Effects 0.000 description 4
230000012010 growth Effects 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
238000010166 immunofluorescence Methods 0.000 description 4
238000010348 incorporation Methods 0.000 description 4
230000001524 infective effect Effects 0.000 description 4
239000002609 medium Substances 0.000 description 4
239000002773 nucleotide Substances 0.000 description 4
125000003729 nucleotide group Chemical group 0.000 description 4
230000002035 prolonged effect Effects 0.000 description 4
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
210000000952 spleen Anatomy 0.000 description 4
210000004989 spleen cell Anatomy 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 3
241000726306 Irus Species 0.000 description 3
108010023244 Lactoperoxidase Proteins 0.000 description 3
102000045576 Lactoperoxidases Human genes 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
108010058846 Ovalbumin Proteins 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
108091081062 Repeated sequence (DNA) Proteins 0.000 description 3
108010008038 Synthetic Vaccines Proteins 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
238000009835 boiling Methods 0.000 description 3
238000005520 cutting process Methods 0.000 description 3
230000034994 death Effects 0.000 description 3
231100000517 death Toxicity 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
208000000292 ehrlichiosis Diseases 0.000 description 3
238000001962 electrophoresis Methods 0.000 description 3
239000012894 fetal calf serum Substances 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
230000036039 immunity Effects 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
150000002500 ions Chemical class 0.000 description 3
238000002955 isolation Methods 0.000 description 3
229940057428 lactoperoxidase Drugs 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000013507 mapping Methods 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
244000005700 microbiome Species 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
229940092253 ovalbumin Drugs 0.000 description 3
230000003071 parasitic effect Effects 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
-1 red C?llS Proteins 0.000 description 3
230000004044 response Effects 0.000 description 3
206010039766 scrub typhus Diseases 0.000 description 3
229940083575 sodium dodecyl sulfate Drugs 0.000 description 3
235000019333 sodium laurylsulphate Nutrition 0.000 description 3
238000000527 sonication Methods 0.000 description 3
239000000725 suspension Substances 0.000 description 3
238000005406 washing Methods 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
241000282465 Canis Species 0.000 description 2
102000003846 Carbonic anhydrases Human genes 0.000 description 2
108090000209 Carbonic anhydrases Proteins 0.000 description 2
108090001069 Chymopapain Proteins 0.000 description 2
241000725101 Clea Species 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
108091035707 Consensus sequence Proteins 0.000 description 2
241001131785 Escherichia coli HB101 Species 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
108010051815 Glutamyl endopeptidase Proteins 0.000 description 2
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
239000012981 Hank's balanced salt solution Substances 0.000 description 2
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
102000012750 Membrane Glycoproteins Human genes 0.000 description 2
108010090054 Membrane Glycoproteins Proteins 0.000 description 2
108010085220 Multiprotein Complexes Proteins 0.000 description 2
102000007474 Multiprotein Complexes Human genes 0.000 description 2
102000003505 Myosin Human genes 0.000 description 2
108060008487 Myosin Proteins 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
108010076504 Protein Sorting Signals Proteins 0.000 description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
208000034712 Rickettsia Infections Diseases 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
206010000210 abortion Diseases 0.000 description 2
231100000176 abortion Toxicity 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
230000007910 cell fusion Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
230000000112 colonic effect Effects 0.000 description 2
230000037029 cross reaction Effects 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
229940009976 deoxycholate Drugs 0.000 description 2
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 2
108020001507 fusion proteins Proteins 0.000 description 2
102000037865 fusion proteins Human genes 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
230000002480 immunoprotective effect Effects 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 2
239000000463 material Substances 0.000 description 2
238000005259 measurement Methods 0.000 description 2
239000012528 membrane Substances 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
238000012510 peptide mapping method Methods 0.000 description 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
230000017854 proteolysis Effects 0.000 description 2
238000000163 radioactive labelling Methods 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
239000012723 sample buffer Substances 0.000 description 2
229940016590 sarkosyl Drugs 0.000 description 2
108700004121 sarkosyl Proteins 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
210000002268 wool Anatomy 0.000 description 2
BAAVRTJSLCSMNM-CMOCDZPBSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]pentanedioic acid Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 BAAVRTJSLCSMNM-CMOCDZPBSA-N 0.000 description 1
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
101150042997 21 gene Proteins 0.000 description 1
XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 1
241000238876 Acari Species 0.000 description 1
101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
241001136792 Alle Species 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
241000606643 Anaplasma centrale Species 0.000 description 1
208000031295 Animal disease Diseases 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
240000003291 Armoracia rusticana Species 0.000 description 1
241000238421 Arthropoda Species 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
241000271566 Aves Species 0.000 description 1
241000223836 Babesia Species 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
101100257137 Caenorhabditis elegans sma-6 gene Proteins 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
XXAXVMUWHZHZMJ-UHFFFAOYSA-N Chymopapain Chemical compound OC1=CC(S(O)(=O)=O)=CC(S(O)(=O)=O)=C1O XXAXVMUWHZHZMJ-UHFFFAOYSA-N 0.000 description 1
241000518994 Conta Species 0.000 description 1
238000011537 Coomassie blue staining Methods 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
241000255925 Diptera Species 0.000 description 1
241001050985 Disco Species 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
241000605314 Ehrlichia Species 0.000 description 1
241000605312 Ehrlichia canis Species 0.000 description 1
206010014979 Epidemic typhus Diseases 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
108010000916 Fimbriae Proteins Proteins 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
229920002971 Heparan sulfate Polymers 0.000 description 1
101000852483 Homo sapiens Interleukin-1 receptor-associated kinase 1 Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
241000283160 Inia Species 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
102100036342 Interleukin-1 receptor-associated kinase 1 Human genes 0.000 description 1
241001527806 Iti Species 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
101150078994 La gene Proteins 0.000 description 1
241000408529 Libra Species 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241001024304 Mino Species 0.000 description 1
241000087624 Monoclona Species 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101000985498 Mus musculus Hermansky-Pudlak syndrome 4 protein homolog Proteins 0.000 description 1
101100238304 Mus musculus Morc1 gene Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
241000588652 Neisseria gonorrhoeae Species 0.000 description 1
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
108010065081 Phosphorylase b Proteins 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
241000588769 Proteus <enterobacteria> Species 0.000 description 1
206010037688 Q fever Diseases 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
208000037656 Respiratory Sounds Diseases 0.000 description 1
206010039207 Rocky Mountain Spotted Fever Diseases 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
208000031726 Spotted Fever Group Rickettsiosis Diseases 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
101150057833 THEG gene Proteins 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
241000096130 Toxopus brucei Species 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
241001523432 Zale Species 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
208000011804 anaplasmosis in cattle Diseases 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
230000002547 anomalous effect Effects 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
201000008680 babesiosis Diseases 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
229960002319 barbital Drugs 0.000 description 1
HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
125000000837 carbohydrate group Chemical group 0.000 description 1
108091092328 cellular RNA Proteins 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000003501 co-culture Methods 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000003544 deproteinization Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
239000005546 dideoxynucleotide Substances 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
229940051998 ehrlichia canis Drugs 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical group C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
229960005293 etodolac Drugs 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000011491 glass wool Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
238000005534 hematocrit Methods 0.000 description 1
230000002949 hemolytic effect Effects 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
238000002169 hydrotherapy Methods 0.000 description 1
230000008073 immune recognition Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
239000003547 immunosorbent Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
244000144972 livestock Species 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
239000006166 lysate Substances 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
MIKKOBKEXMRYFQ-WZTVWXICSA-N meglumine amidotrizoate Chemical compound C[NH2+]C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I MIKKOBKEXMRYFQ-WZTVWXICSA-N 0.000 description 1
KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
229960004963 mesalazine Drugs 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
230000035772 mutation Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
238000012809 post-inoculation Methods 0.000 description 1
ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000004321 preservation Methods 0.000 description 1
238000003825 pressing Methods 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
206010037833 rales Diseases 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
229940124551 recombinant vaccine Drugs 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
229920003987 resole Polymers 0.000 description 1
102220041208 rs141802836 Human genes 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000007017 scission Effects 0.000 description 1
239000013049 sediment Substances 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
101150115956 slc25a26 gene Proteins 0.000 description 1
239000002002 slurry Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
201000004284 spotted fever Diseases 0.000 description 1
238000010186 staining Methods 0.000 description 1
230000003068 static effect Effects 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
108010010318 streptococcal M protein Proteins 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
238000012353 t test Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
239000003104 tissue culture media Substances 0.000 description 1
229910052719 titanium Inorganic materials 0.000 description 1
239000010936 titanium Substances 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000005945 translocation Effects 0.000 description 1
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
108010032276 tyrosyl-glutamyl-tyrosyl-glutamic acid Proteins 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1
230000004580 weight loss Effects 0.000 description 1
238000001262 western blot Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA002049986A 1989-04-06 1990-03-30 Antigenes de ricketties a des fins de vaccination et de diagnostique Abandoned CA2049986A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US33517889A	1989-04-06	1989-04-06
US335,178		1989-04-06
PCT/US1990/001678 WO1990012030A1 (fr)	1989-04-06	1990-03-30	Antigenes de la bacterie de rickettsia pour la vaccination et le diagnostic

Publications (1)

Publication Number	Publication Date
CA2049986A1 true CA2049986A1 (fr)	1990-10-07

Family

ID=23310630

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002049986A Abandoned CA2049986A1 (fr)	1989-04-06	1990-03-30	Antigenes de ricketties a des fins de vaccination et de diagnostique

Country Status (4)

Country	Link
EP (1)	EP0467972A4 (fr)
JP (1)	JPH04504422A (fr)
CA (1)	CA2049986A1 (fr)
WO (1)	WO1990012030A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69122280T2 (de) *	1990-03-01	1997-04-24	Hewlett Packard Co	Minimierung von Eluatbandbreiten in der Flüssigchromatographie
ATE212378T1 (de)	1993-06-04	2002-02-15	Whitehead Biomedical Inst	Stressproteine und ihre verwendung
US5869335A (en) *	1995-08-25	1999-02-09	Regents Of The University Of Minnesota	Method of growing rickettsiae in Ixodes scapularis tick cell culture and preparing antigens and vaccines of rickettsiae
US6593147B1 (en)	1996-10-17	2003-07-15	University Of Florida Research Foundation, Inc.	Nucleic acid vaccines against rickettsial diseases and methods of use
US6025338A (en) *	1996-10-17	2000-02-15	University Of Florida	Nucleic acid vaccines against rickettsial diseases and methods of use
US6653128B2 (en)	1996-10-17	2003-11-25	University Of Florida	Nucleic acid vaccines against rickettsial diseases and methods of use
US6964851B2 (en)	1999-12-07	2005-11-15	Stressgen Biotechnologies Corp.	Compositions and methods for detecting stress-inducible proteins
WO2001051081A1 (fr)	2000-01-14	2001-07-19	Whitehead Institute For Biomedical Research	L'elicitation in vivo des ctl par des proteines de fusion de la proteine de choc thermique correspond a un domaine discret de liaison de l'atp et est independante des cellules cd4?+¿
WO2013113000A2 (fr)	2012-01-26	2013-08-01	Luc Montagnier	Détection de séquences d'adn en tant que facteurs de risque d'une infection par le vih
JP6311959B2 (ja) *	2012-10-04	2018-04-18	国立大学法人三重大学	微生物の迅速診断を可能とする特異抗体の高効率作製法

1990
- 1990-03-30 WO PCT/US1990/001678 patent/WO1990012030A1/fr not_active Ceased
- 1990-03-30 JP JP2506421A patent/JPH04504422A/ja active Pending
- 1990-03-30 CA CA002049986A patent/CA2049986A1/fr not_active Abandoned
- 1990-03-30 EP EP19900906659 patent/EP0467972A4/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP0467972A1 (fr)	1992-01-29
WO1990012030A1 (fr)	1990-10-18
EP0467972A4 (en)	1992-09-02
JPH04504422A (ja)	1992-08-06

Publication	Publication Date	Title
Akins et al.	1998	A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state.
Lindler et al.	1996	Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis
US5747294A (en)	1998-05-05	Compositions and methods for the prevention and diagnosis of lyme disease
Lanar et al.	1986	Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice
Anders et al.	1998	Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi
JP2907813B2 (ja)	1999-06-21	コクシジウム症予防用抗原性蛋白質およびそれを含有するワクチン
EP0540457A1 (fr)	1993-05-05	Améliorations dans le diagnostic et dans le prophylaxie de Borrelia burgdorferi
SK217292A3 (en)	1998-08-05	Vaccine containing a pc protein useful in prevention of lyme disease, method of b.burgdorferi protein purification, diagnostic agent detecting b.burgdorferi antigens and method of detecting b.burgdorferi antigenes in humoralis
JPH0699475B2 (ja)	1994-12-07	コクシジウムのモノクロ−ナル抗体
US5807685A (en)	1998-09-15	OspE, OspF, and S1 polypeptides in Borrelia burgdorferi
Reduker et al.	1989	A recombinant surface protein of Babesia bovis elicits bovine antibodies that react with live merozoites
CA2049986A1 (fr)	1990-10-07	Antigenes de ricketties a des fins de vaccination et de diagnostique
US5549898A (en)	1996-08-27	Immunogenic anaplasma marginale surface antigens, compositions, and methods of use
EP0348725A2 (fr)	1990-01-03	Epitode spécifique de l'espèce de chlamydia trachomatis et les anticorps le reconnaissant
RU2555530C2 (ru)	2015-07-10	СПОСОБ ИДЕНТИФИКАЦИИ ПОЛИПЕПТИДОВ И БЕЛКОВ H.parasuis
CA1272124A (fr)	1990-07-31	Antigene sous-unitaire de anaplasma marginale a des fins de vaccination et de diagnostic
EP0575348A1 (fr)	1993-12-29	$i(BORRELIA) SANS FLAGELLE
CZ34293A3 (en)	1994-01-19	Preparation for treating tumorous diseases
WO2008055916A9 (fr)	2009-04-16	Nouveaux antigènes permettant le diagnostic de la paratuberculose et la vaccination contre cette dernière
US6710166B1 (en)	2004-03-23	41 kDa Cryptosporidium parvum oocyst wall protein
US5422428A (en)	1995-06-06	Immunization against babesiosis using purified surface antigens of Babesia bigemina and similar immunogens
AU644362B2 (en)	1993-12-09	Rickettsial antigens for vaccination and diagnosis
US6716591B1 (en)	2004-04-06	B. burgdorferi polypeptides
EP0915977A1 (fr)	1999-05-19	Polypeptides du type b. burgdorferi exprimes in vivo
Polonelli et al.	1994	New strategies in vaccination against fungal infections

Legal Events

Date	Code	Title	Description
1995-10-01	FZDE	Discontinued